Results
Senores Pharmaceuticals Q1 PAT Up 56% YoY
Senores Pharmaceuticals reported Q1 FY27 consolidated revenue of ₹180 crore, up 36% YoY, with PAT growing 56% to ₹31 crore.
Management provided FY27 guidance for 30-40% revenue growth and 50-60% PAT g
